Orthopedic Biomaterial Market, By Material Type (Glass-ceramic & Bioactive Glasses, Calcium Phosphate Cements, Polymer, Metals, Composites), By Application (Joint Replacement, Spine Implants, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fix

Orthopedic Biomaterial Market, By Material Type (Glass-ceramic & Bioactive Glasses, Calcium Phosphate Cements, Polymer, Metals, Composites), By Application (Joint Replacement, Spine Implants, Orthobiologics, Viscosupplementation, Bio-resorbable Tissue Fixation), By End User (Hospitals, Orthopedic Clinics, Others), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Orthopedic biomaterials are synthetic or organic materials of biologic composition. Orthopedic biomaterials are commonly used in orthopedics, surgical implants, prosthetics, and various medical tools and devices. These materials are used to internally fix the fracture. Biomaterial devices are designed for various number of orthopedic applications, which are termed as ‘Implants’. The orthopedic biomaterials market involve bone graft substitutes, growth factors, orthopedic stem cells, cell therapy, hyaluronic acid visco supplementation, cartilage repair, and machined bone allografts. These materials are implanted or applied in or near the indicated bone to expedite healing, stimulate bone tissue augmentation, compensate in areas where bone tissue is depleted and restore structure to allow for repair. Various biomaterials used in orthopedic are metals or metal alloys, ceramics, tissue adhesives, polymers, carbon materials, and composites, etc. Metal is the most commonly used orthopedic material due to its properties, such as corrosion resistance, high strength, hardness, ductility, biocompatibility, and formability.
Market Dynamics
Rise in the population with musculoskeletal disorders & chronic skeletal disorders, and increasing geriatric population are some of the major factors responsible for the growth of Global Orthopedic Biomaterial Market. For instance, according to the report published by the United Nation (UN) in 2017, the global population of age 60 and above was around 962 million, and is expected to reach 2.1 billion by 2050. Among orthopedic operations, knee replacement therapy is mostly carried out in geriatrics population. Moreover, according to the Journal of Bone and Joint Surgery, by 2030 the demand for knee arthroplastics is estimated to grow by 674% during 2005 and 2030 reaching 3.48 million procedures.
Key features of the study:
This report provides in-depth analysis of the Global Orthopedic Biomaterial Market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Orthopedic Biomaterial Market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include B. Braun Melsungen AG, CONMED Corp., Evonik Industries AG, Medtronic Plc., Smith & Nephew Plc., Stryker Corp., Victrex Plc., and Zimmer Biomet Holdings Inc., Globus Medical, Heraeus Holding GmbH, Exactech Inc., Collagen Matrix Inc., Koninklijke DSM N.V. (DSM Biomedical B.V.), Invibio Ltd. and DePuy Synthes
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The Global Orthopedic Biomaterial Market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Orthopedic Biomaterial Market.
Detailed Segmentation:
Global Orthopedic Biomaterial Market, By Material Type:
Glass-ceramic & Bioactive Glasses
Calcium Phosphate Cements
Polymer
Metals
Composites
Global Orthopedic Biomaterial Market, By Application:
Joint R eplacement
Spine Implants
Orthobiologics
Viscosupplementation
Bio-resorbable Tissue Fixation
Global Orthopedic Biomaterial Market, By End user:
Hospitals
Orthopedic Clinics
Other
Global Orthopedic Biomaterial Market, By Region:
North America
U.S.
Canada
Latin America
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC
Israel
Rest of Middle East
Africa
South Africa
Central Africa
North Africa
Company Profiles
B.Braun Melsungen AG
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
CONMED Corporation
Evonik Industries AG
Medtronic Plc.
Smith & Nephew Plc.
Stryker Corp
Victrex Plc.
Zimmer Biomet Holdings Inc.
Globus Medical
Heraeus Holding GmbH
Exactech Inc.
Collagen Matrix Inc.
Koninklijke DSM N.V. (DSM Biomedical B.V.),
Invibio Ltd.
DePuy Synthes
“*” marked represents similar segmentation in other categories in the respective section.